NASDAQ: ZCMDZhongchao Inc Stock
$0.32-0.04 (-11.11%)
Updated Jun 26, 2026
ZCMD Price
$0.32
Fair Value Price
N/A
Market Cap
$39.61k
52 Week Low
$0.30
52 Week High
$322.65
P/E
-0.01x
P/B
0x
P/S
1.08x
PEG
N/A
Dividend Yield
N/A
Revenue
$11.37M
Earnings
-$6.31M
Gross Margin
45%
Operating Margin
-55.07%
Profit Margin
-55.5%
Debt to Equity
0.08
Operating Cash Flow
$845k
Beta
0.21
Next Earnings
Jul 3, 2026
Ex-Dividend
N/A
Next Dividend
N/A
ZCMD Overview
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People’s Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, including the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ZCMD's potential to beat the market
- ZCMD doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
ZCMD
RankedUnranked of 43
RankedUnranked of 43
Be the first to know about important ZCMD news, forecast changes, insider trades & much more!
ZCMD News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ZCMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ZCMD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ZCMD is good value based on its book value relative to its share price (0x), compared to the US Health Information Services industry average (3.28x)
P/B vs Industry Valuation
ZCMD is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ZCMD due diligence checks available for Premium users.
Valuation
ZCMD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.01x
Industry
12.84x
Market
12.39x
ZCMD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0x
Industry
3.28x
ZCMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ZCMD's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
ZCMD's Earnings (EBIT) of -$6.26M... subscribe to Premium to read more.
Interest Coverage Financials
ZCMD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$24.1M
Liabilities
$1.5M
Debt to equity
0.08
ZCMD's short-term assets ($16.96M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZCMD's short-term assets ($16.96M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZCMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ZCMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
ZCMD's operating cash flow ($845.39k)... subscribe to Premium to read more.
Debt Coverage Financials
ZCMD vs Health Information Service Stocks
Zhongchao Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.